Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.
OBESITY RESEARCH SOLUTIONSDorzagliatin is an activator of glucokinase.1 It increases hepatic levels of glucokinase and pancreatic levels of insulin in a rat model of diabetes induced by streptozotocin (Item No. 13104) and a high-fat diet (HFD) when administered at doses of 10 or 30 mg/kg per day. Dorzagliatin (10 or 30 mg/kg) decreases blood levels of glucose in an oral glucose tolerance test (OGTT) in the same model. Formulations containing dorzagliatin have been used in the treatment of type 2 diabetes.
WARNING This product is not for human or veterinary use.
1. Effects of a novel glucokinase activator, HMS5552, on glucose metabolism in a rat model of type 2 diabetes mellitus. J. Diabetes Res. 5812607 (2017).